Product profile · UK declaration
Lily’s Kitchen Chicken Paté Cat Food
A wet chicken paté for adult cats, supplied in 85g portions.
Product and intended use
The checked page covers a 19 × 85g multipack and also lists individual 85g portions. Compare the declaration on your own pack if packaging changes.
“Complete” records the manufacturer’s description. It is not an Evidence.pet certification or an independent nutrient analysis.
Declared nutritional analysis
Manufacturer figures, as sold. These are not independent batch-test results. Water content differs between food formats, so the percentages should not be used alone to rank wet, raw and dry foods.
| Component | Declared value |
|---|---|
| Protein | 9.5% |
| Fat | 6% |
| Fibre | 0.3% |
| Ash | 2.2% |
| Moisture | 82% |
| Declared energy | 88 kcal/100g |
What is in it?
Chicken is declared at 65%, with minerals. The additives panel separately lists taurine at 804mg/kg; an added amount is not necessarily the food’s total taurine content.
This is a summary. The source and the current pack provide the complete declaration, including additives. Ingredient presence alone does not establish digestibility, nutritional adequacy or clinical benefit.
Claims and evidence
The manufacturer describes a complete, grain-free food with no added sugar. These declarations do not establish superiority over other complete diets.
No published trial of this exact current formulation has been verified for this entry. This is a limit of our review, not a claim that no research exists.
Taurine information explains the nutrient’s role, but does not independently verify the adequacy or clinical performance of this particular recipe.
Explore ingredients and research
Browse cat studies · Browse ingredients for cats
Related studies provide context. Check the actual animals, diet, dose and outcome before transferring a finding to this food.
Source and review scope
Official UK product information · Lily’s Kitchen brand profile
Evidence.pet record PRO-008. Checked 23 September 2026. Next review planned 23 December 2026. No independent batch testing or formal efficacy grade. Formulations may change; check your current pack.